,bcr_patient_uuid,patient_ID,bcr_drug_barcode,bcr_drug_uuid,form_completion_date,pharmaceutical_therapy_drug_name,clinical_trial_drug_classification,pharmaceutical_therapy_type,days_to_drug_start,pharmaceutical_tx_ongoing_indicator,days_to_drug_end,treatment_best_response,days_to_stem_cell_transplantation,pharm_regimen,pharm_regimen_other,stem_cell_transplantation,stem_cell_transplantation_type,therapy_on_clinical_trial
1,83b3060c-2449-4581-88ef-817d126e4525,TCGA.KL.8323,TCGA-KL-8323-D33911,5EDBDBA5-8EE3-45E6-B0A5-5948DA3689A5,2012-7-24,LYMPHOCYTE INFUSION,NA,IMMUNOTHERAPY,880,FALSE,NA,NA,NA,NA,NA,NA,NA,FALSE
2,83b3060c-2449-4581-88ef-817d126e4525,TCGA.KL.8323,TCGA-KL-8323-D33912,69C8BF63-23C1-46D5-AFB8-7192AFB58760,2012-7-24,PTK-ZK,NA,TARGETED MOLECULAR THERAPY,911,FALSE,942,NA,NA,NA,NA,NA,NA,TRUE
3,63643ba6-bed9-4c36-91dd-a18105fadc06,TCGA.KL.8336,TCGA-KL-8336-D33939,C706BEA1-7CC9-4D8A-ABCC-51DD05EFE077,2012-7-24,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,138,FALSE,559,NA,NA,NA,NA,NA,NA,FALSE
4,63643ba6-bed9-4c36-91dd-a18105fadc06,TCGA.KL.8336,TCGA-KL-8336-D33940,6251213A-2CA9-4E23-BB20-356074A881A8,2012-7-24,TEMSIROLIMUS,NA,CHEMOTHERAPY,558,FALSE,817,NA,NA,NA,NA,NA,NA,FALSE
5,63643ba6-bed9-4c36-91dd-a18105fadc06,TCGA.KL.8336,TCGA-KL-8336-D33941,74B0A250-2C27-49BB-9ED5-9E2994C6CF9A,2012-7-24,BEVACIZUMAB,NA,CHEMOTHERAPY,824,FALSE,838,NA,NA,NA,NA,NA,NA,FALSE
6,e0e38071-877f-4ebf-955f-483eb4865351,TCGA.KL.8339,TCGA-KL-8339-D32704,C00D326B-2D48-4084-9F21-5C04D5E27BC9,2012-6-7,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,111,FALSE,251,NA,NA,NA,NA,NA,NA,FALSE
7,70e306ee-9584-49d6-81a1-a49d837ab6aa,TCGA.KL.8341,TCGA-KL-8341-D33919,6463DA70-D7C2-4BB5-84E9-6C5AACDD0E94,2012-7-24,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,196,FALSE,366,NA,NA,NA,NA,NA,NA,TRUE
8,70e306ee-9584-49d6-81a1-a49d837ab6aa,TCGA.KL.8341,TCGA-KL-8341-D33922,D4BBFA8D-71E0-4F62-B628-C833F75DFDE9,2012-7-24,BEVACIZUMAB,NA,CHEMOTHERAPY,196,FALSE,366,NA,NA,NA,NA,NA,NA,TRUE
9,70e306ee-9584-49d6-81a1-a49d837ab6aa,TCGA.KL.8341,TCGA-KL-8341-D33923,AC4D913B-061E-41B9-A504-8E63C9A93D00,2012-7-24,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,397,FALSE,457,NA,NA,NA,NA,NA,NA,FALSE
10,70e306ee-9584-49d6-81a1-a49d837ab6aa,TCGA.KL.8341,TCGA-KL-8341-D33924,E922EBC8-97A1-4B90-8D38-5CDD480BE0D5,2012-7-24,TEMSIROLIMUS,NA,CHEMOTHERAPY,567,FALSE,609,NA,NA,NA,NA,NA,NA,FALSE
11,70e306ee-9584-49d6-81a1-a49d837ab6aa,TCGA.KL.8341,TCGA-KL-8341-D33925,6C137653-E683-420B-B63B-F2C57B064041,2012-7-24,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,624,FALSE,NA,NA,NA,NA,NA,NA,NA,FALSE
12,23656226-2d99-4548-959f-5c2eed803e33,TCGA.KM.8438,TCGA-KM-8438-D32859,1574D627-CF11-42BA-94C3-3F5854A4C649,2012-6-14,SUTENT,NA,TARGETED MOLECULAR THERAPY,2342,FALSE,2731,NA,NA,NA,NA,NA,NA,FALSE
13,23656226-2d99-4548-959f-5c2eed803e33,TCGA.KM.8438,TCGA-KM-8438-D32860,2D6C5401-74D1-4080-B9FD-8C94D19C5A99,2012-6-14,TEMSIROLIMUS,NA,TARGETED MOLECULAR THERAPY,2731,FALSE,4436,NA,NA,NA,NA,NA,NA,FALSE
14,23656226-2d99-4548-959f-5c2eed803e33,TCGA.KM.8438,TCGA-KM-8438-D32861,6442C5A4-A38C-487D-95A2-9BD3EB249787,2012-6-14,BEVACIZUMAB,NA,TARGETED MOLECULAR THERAPY,3554,FALSE,3858,NA,NA,NA,NA,NA,NA,FALSE
15,8D30C7BE-73B6-4C4C-80C5-31152B2F7CB0,TCGA.KM.A7Q8,TCGA-KM-A7Q8-D62492,3789FA17-816C-4768-A1FE-E8E49373B5BC,2014-7-21,SUNITINIB,NA,TARGETED MOLECULAR THERAPY,NA,FALSE,NA,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,FALSE
16,b08dfba8-6afb-4217-9259-72be6f1f3363,TCGA.KN.8426,TCGA-KN-8426-D34188,36E267F1-1DC3-404E-830B-B58767C04AA0,2012-8-10,AVASTIN,NA,TARGETED MOLECULAR THERAPY,NA,FALSE,NA,NA,NA,NA,NA,NA,NA,FALSE
17,b08dfba8-6afb-4217-9259-72be6f1f3363,TCGA.KN.8426,TCGA-KN-8426-D39303,6330F707-EA10-4F3C-916C-3C0292CD7E85,2013-1-16,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,NA,FALSE,NA,NA,NA,NA,NA,NA,NA,FALSE
18,455fd7d4-5ff4-423f-83ce-4630aef89bb7,TCGA.KN.8428,TCGA-KN-8428-D34187,FD53289F-BFB3-419C-A907-26053E04B068,2012-8-17,SORAFENIB,NA,TARGETED MOLECULAR THERAPY,510,FALSE,638,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,FALSE
19,11a33d4a-4839-468f-9d61-5630586ed978,TCGA.KO.8404,TCGA-KO-8404-D43064,5052518A-3E22-436D-B3B1-8702F9B49526,2013-5-9,THALIDOMIDE,NA,CHEMOTHERAPY,117,FALSE,139,PROGRESSIVE DISEASE,NA,NA,NA,NA,NA,TRUE
20,A86C2490-37DA-46A3-88E2-0B0CE21D067F,TCGA.UW.A7GR,TCGA-UW-A7GR-D54190,5B20A89E-1F30-4D80-B29F-F57E09B5BA9E,2013-12-17,INTERFERON,NA,IMMUNOTHERAPY,22,FALSE,288,PARTIAL RESPONSE,NA,NA,NA,NA,NA,TRUE
21,A86C2490-37DA-46A3-88E2-0B0CE21D067F,TCGA.UW.A7GR,TCGA-UW-A7GR-D54191,3237FFE4-790D-4C54-8F2B-F5B75B60D901,2013-12-17,SORAFENIB,NA,CHEMOTHERAPY,22,FALSE,288,PARTIAL RESPONSE,NA,NA,NA,NA,NA,TRUE
